Insider · CIK 0001028775

BAKER DOUGLAS P

Reports to the SEC for 2 companies · AUSTIN,, TX

sec.gov

Transactions

Companies

Filings

CIK

0001028775

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-10-05	OPRXOptimizeRx Corp · Stock OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−10K sh	$7.51	−$75.1K	34,699
2021-10-05	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−10K sh	$82.35	−$824K	34,796
2021-10-05	OPRXOptimizeRx CorpM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+10K sh	$7.51	+$75.1K	44,796
2021-10-05	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−4,000 sh	$84.22	−$337K	34,796
2021-09-28	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−2,000 sh	$74.66	−$149K	38,796
2021-09-21	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−4,000 sh	$70.59	−$282K	40,796
2021-09-14	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−3,768 sh	$65.57	−$247K	44,796
2021-09-08	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−10K sh	$67.25	−$673K	48,564
2021-09-08	OPRXOptimizeRx CorpM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+10K sh	$7.51	+$75.1K	58,564
2021-09-08	OPRXOptimizeRx Corp · Stock OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−10K sh	$7.51	−$75.1K	44,699
2021-09-07	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−2,232 sh	$70.53	−$157K	48,564
2021-08-31	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−4,000 sh	$66.62	−$266K	50,796
2021-08-24	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−4,000 sh	$61.50	−$246K	54,796
2021-08-20	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−5,000 sh	$58.45	−$292K	58,796
2021-08-17	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−4,000 sh	$58.46	−$234K	63,796
2021-08-13	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−5,000 sh	$63.27	−$316K	67,796
2021-08-10	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−2,000 sh	$64.50	−$129K	72,796
2021-08-09	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−10K sh	$64.31	−$643K	64,796
2021-08-09	OPRXOptimizeRx Corp · Stock OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−10K sh	$7.51	−$75.1K	54,699
2021-08-09	OPRXOptimizeRx CorpM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+10K sh	$7.51	+$75.1K	74,796
2021-08-03	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−2,000 sh	$54.93	−$110K	74,796
2021-07-27	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−3,000 sh	$52.58	−$158K	76,796
2021-07-20	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−3,000 sh	$50.90	−$153K	79,796
2021-07-08	OPRXOptimizeRx Corp · Stock OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−13.4K sh	—	—	64,699
2021-07-08	OPRXOptimizeRx CorpM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+13.4K sh	$2.46	+$33.1K	82,796
2021-07-08	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−13.4K sh	$56.05	−$753K	69,361
2021-06-28	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−3,421 sh	$63.00	−$216K	82,796
2021-06-24	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−4,000 sh	$60.00	−$240K	86,217
2021-06-07	OPRXOptimizeRx CorpM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+14.5K sh	$2.46	+$35.7K	90,217
2021-06-07	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−14.5K sh	$52.62	−$763K	75,717
2021-06-07	OPRXOptimizeRx Corp · Stock OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−14.5K sh	—	—	78,134
2021-05-18	OPRXOptimizeRx CorpM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+14.5K sh	$2.46	+$35.7K	90,217
2021-05-18	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−14.5K sh	$45.85	−$665K	75,717
2021-05-18	OPRXOptimizeRx Corp · Stock OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−14.5K sh	—	—	92,634
2021-01-29	OPRXOptimizeRx CorpM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+4,315 sh	$7.51	+$32.4K	90,217
2021-01-29	OPRXOptimizeRx Corp · Stock OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−4,315 sh	$7.51	−$32.4K	107,134
2021-01-29	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−5,032 sh	$47.25	−$238K	85,902
2021-01-13	OPRXOptimizeRx Corp · Stock OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−5,000 sh	$7.51	−$37.6K	96,993
2021-01-13	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−5,000 sh	$38.89	−$194K	85,937
2021-01-13	OPRXOptimizeRx CorpM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+5,000 sh	$7.51	+$37.6K	90,937
2021-01-07	OPRXOptimizeRx Corp · Stock OptionA Award	CHIEF FINANCIAL OFFICER	AAward	+14.5K sh	—	—	116,449
2021-01-04	OPRXOptimizeRx CorpM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+4,000 sh	$7.51	+$30K	90,937
2021-01-04	OPRXOptimizeRx CorpM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+4,566 sh	$2.46	+$11.2K	86,937
2021-01-04	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−8,334 sh	$32.88	−$274K	82,371
2021-01-04	OPRXOptimizeRx Corp · Stock OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−4,000 sh	$7.51	−$30K	101,993
2021-01-04	OPRXOptimizeRx Corp · Stock OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−4,566 sh	$2.46	−$11.2K	105,993
2020-11-12	OPRXOptimizeRx CorpM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+15K sh	$2.46	+$36.9K	90,705
2020-11-12	OPRXOptimizeRx Corp · Stock OptionM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−15K sh	$2.46	−$36.9K	110,559
2020-11-11	OPRXOptimizeRx CorpS Sale	CHIEF FINANCIAL OFFICER	SSale	−15K sh	$24.05	−$361K	75,705
2020-09-02	OPRXOptimizeRx CorpM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+10K sh	$2.46	+$24.6K	90,705

Recent filings

Accepted (ET)
Oct 54
BAKER DOUGLAS P0001213900-21-051449
SEC(opens sec.gov)
Sep 294
BAKER DOUGLAS P0001213900-21-050600
SEC(opens sec.gov)
Sep 224
BAKER DOUGLAS P0001213900-21-049366
SEC(opens sec.gov)
Sep 154
BAKER DOUGLAS P0001213900-21-048250
SEC(opens sec.gov)
Sep 94
BAKER DOUGLAS P0001213900-21-047223
SEC(opens sec.gov)
Sep 24
BAKER DOUGLAS P0001213900-21-046409
SEC(opens sec.gov)
Aug 244
BAKER DOUGLAS P0001213900-21-044609
SEC(opens sec.gov)
Aug 174
BAKER DOUGLAS P0001213900-21-043479
SEC(opens sec.gov)
Aug 104
BAKER DOUGLAS P0001213900-21-041400
SEC(opens sec.gov)

Companies

Address

3006 LONGHORN BLVD., SUITE 107

AUSTIN,, TX, 78758